Publication | Closed Access

A Phase II Trial of Dose-Dense Neoadjuvant Gemcitabine, Epirubicin, and Albumin-Bound Paclitaxel With Pegfilgrastim in the Treatment of Patients With Locally Advanced Breast Cancer

Breast OncologyOncologyPhase Ii TrialMedicineAlbumin-bound PaclitaxelBreast CancerPharmacotherapyAnti-cancer AgentCancer TreatmentDose-dense Neoadjuvant GemcitabinePharmacology